200,000+ products from a single source!
sales@angenechem.com
Home > Imidazoles > 1282512-48-4
CAS No: 1282512-48-4 Catalog No: AG000XWI MDL No:MFCD26142641
Title | Journal |
---|---|
Taselisib, a selective inhibitor of PIK3CA, is highly effective on PIK3CA-mutated and HER2/neu amplified uterine serous carcinoma in vitro and in vivo. | Gynecologic oncology 20141101 |
Discovery of 2-{3-[2-(1-isopropyl-3-methyl-1H-1,2-4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl]-1H-pyrazol-1-yl}-2-methylpropanamide (GDC-0032): a β-sparing phosphoinositide 3-kinase inhibitor with high unbound exposure and robust in vivo antitumor activity. | Journal of medicinal chemistry 20130613 |
© 2019 Angene International Limited. All rights Reserved.